Maxalt-MLT

Active Ingredient(s): Rizatriptan
First Approved by the FDA: June 29, 1998
Pharmaceutical Company: MERCK

Welcome to the Maxalt-MLT information hub.
Scroll down to read supplemental details and discuss this drug.

Maxalt-MLT Overview

Rizatriptan (trade name Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT). Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan. Rizatriptan is available only by prescription in Australia, the United States, Canada and New Zealand. Similarly, it is classed a ...

Read more Maxalt-MLT Details
Details May Include Instructions, Side Effects, Interactions, Etc.
Drug monograph is from Wikipedia. All text is available under the terms of the GFDL
(GNU Free Documentation License) | http://en.wikipedia.org/wiki/Rizatriptan

Recent Maxalt-MLT Forums:

migraines
I have migraines 3 to 4 times a month. I have lost my job and have no insurance. My Dr. has give me sample of your product and it has works well. Could you please send me some samples. Thank You do much Jill Hodge
Thursday, 2/25/2010 12:27:59 PM 1 Reply Subscribe to thread 201585

Possible Dosages for this and Related Drugs:

Rizatriptan

Tablet: 10mg, 5mg
Tablet, Orally Disintegrated: 10mg, 5mg
Tablet, Orally Disintegrating: 10mg, 5mg

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Rizatriptan or a similar ingredient: (2 results)

Maxalt Rizatriptan
Rizatriptan

Possibly related Maxalt-MLT Topics:

maxalt MLT used for migraines...
maxalt for migraines...
Mazalt-MLT rizatriptan benzoate ...